Herbal Medicine - Open Access Journals

High Impact List of Articles

• The handling of missing data in clinical trials Michael G Kenward

  Clinical Trail Methodology: Clinical Investigation

• The handling of missing data in clinical trials Michael G Kenward

  Clinical Trail Methodology: Clinical Investigation

• The handling of missing data in clinical trials Michael G Kenward

  Clinical Trail Methodology: Clinical Investigation

• The handling of missing data in clinical trials Michael G Kenward

  Clinical Trail Methodology: Clinical Investigation

• The handling of missing data in clinical trials Michael G Kenward

  Clinical Trail Methodology: Clinical Investigation

• The handling of missing data in clinical trials Michael G Kenward

  Clinical Trail Methodology: Clinical Investigation

• The handling of missing data in clinical trials Michael G Kenward

  Clinical Trail Methodology: Clinical Investigation

• The handling of missing data in clinical trials Michael G Kenward

  Clinical Trail Methodology: Clinical Investigation

• Trial discontinuation: lessons for future trial design? Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude

  Clinical Trail Methodology: Clinical Investigation

• Trial discontinuation: lessons for future trial design? Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude

  Clinical Trail Methodology: Clinical Investigation

• Trial discontinuation: lessons for future trial design? Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude

  Clinical Trail Methodology: Clinical Investigation

• Trial discontinuation: lessons for future trial design? Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude

  Clinical Trail Methodology: Clinical Investigation

• Trial discontinuation: lessons for future trial design? Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude

  Clinical Trail Methodology: Clinical Investigation

• Trial discontinuation: lessons for future trial design? Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude

  Clinical Trail Methodology: Clinical Investigation

• Trial discontinuation: lessons for future trial design? Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude

  Clinical Trail Methodology: Clinical Investigation

• Trial discontinuation: lessons for future trial design? Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude

  Clinical Trail Methodology: Clinical Investigation

• Pharmacodynamic end points in early phase oncology trials Giovanna Speranza, James H Doroshow, Shivaani Kummar

  Clinical Trail Perspective: Clinical Investigation

• Pharmacodynamic end points in early phase oncology trials Giovanna Speranza, James H Doroshow, Shivaani Kummar

  Clinical Trail Perspective: Clinical Investigation

• Pharmacodynamic end points in early phase oncology trials Giovanna Speranza, James H Doroshow, Shivaani Kummar

  Clinical Trail Perspective: Clinical Investigation

• Pharmacodynamic end points in early phase oncology trials Giovanna Speranza, James H Doroshow, Shivaani Kummar

  Clinical Trail Perspective: Clinical Investigation

• Pharmacodynamic end points in early phase oncology trials Giovanna Speranza, James H Doroshow, Shivaani Kummar

  Clinical Trail Perspective: Clinical Investigation

• Pharmacodynamic end points in early phase oncology trials Giovanna Speranza, James H Doroshow, Shivaani Kummar

  Clinical Trail Perspective: Clinical Investigation

• Pharmacodynamic end points in early phase oncology trials Giovanna Speranza, James H Doroshow, Shivaani Kummar

  Clinical Trail Perspective: Clinical Investigation

• Pharmacodynamic end points in early phase oncology trials Giovanna Speranza, James H Doroshow, Shivaani Kummar

  Clinical Trail Perspective: Clinical Investigation

• Anti-angiogenic therapy for prostate cancer: rationale and ongoing trials Bamidele A Adesunloye, William L Dahut

  Therapeutic Prospective: Clinical Investigation

• Anti-angiogenic therapy for prostate cancer: rationale and ongoing trials Bamidele A Adesunloye, William L Dahut

  Therapeutic Prospective: Clinical Investigation

• Anti-angiogenic therapy for prostate cancer: rationale and ongoing trials Bamidele A Adesunloye, William L Dahut

  Therapeutic Prospective: Clinical Investigation

• Anti-angiogenic therapy for prostate cancer: rationale and ongoing trials Bamidele A Adesunloye, William L Dahut

  Therapeutic Prospective: Clinical Investigation

• Anti-angiogenic therapy for prostate cancer: rationale and ongoing trials Bamidele A Adesunloye, William L Dahut

  Therapeutic Prospective: Clinical Investigation

• Anti-angiogenic therapy for prostate cancer: rationale and ongoing trials Bamidele A Adesunloye, William L Dahut

  Therapeutic Prospective: Clinical Investigation

• Anti-angiogenic therapy for prostate cancer: rationale and ongoing trials Bamidele A Adesunloye, William L Dahut

  Therapeutic Prospective: Clinical Investigation

• Anti-angiogenic therapy for prostate cancer: rationale and ongoing trials Bamidele A Adesunloye, William L Dahut

  Therapeutic Prospective: Clinical Investigation

• Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications Dilip Nazareth, Peter Davies

  Editorial: Clinical Investigation

• Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications Dilip Nazareth, Peter Davies

  Editorial: Clinical Investigation

• Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications Dilip Nazareth, Peter Davies

  Editorial: Clinical Investigation

• Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications Dilip Nazareth, Peter Davies

  Editorial: Clinical Investigation

• Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications Dilip Nazareth, Peter Davies

  Editorial: Clinical Investigation

• Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications Dilip Nazareth, Peter Davies

  Editorial: Clinical Investigation

• Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications Dilip Nazareth, Peter Davies

  Editorial: Clinical Investigation

• Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications Dilip Nazareth, Peter Davies

  Editorial: Clinical Investigation

Relevant Topics in Clinical